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ABSTRACT

Cord blood storage, use, and donation is a rising trend. The cells found in the blood of the
umbilical cord can be used to treat various life threatening diseases. It has been shown that the
use of these cells can produce results that are just as effective as a bone marrow transfusion.
The yield of cells from a sample of cord blood is not always enough to be effective for a
transfusion in adults. As such children are the primary demographic for cord blood transfusions.
For this reason, prospective parents are taking notice of the trend.
Currently, federal and state statutes are set up to promote the introduction of cord blood
use. What current law fails to recognize is that cord blood is in use and has a lot of potential. For
this reason laws need to be updated to better reflect the current market. A more proactive
approach needs to be taken to better utilize the potential of cord blood.
As the trend is popularized there is an increasing notion that informed consent is not
uniform enough, state laws do not adequately promote cord blood use, and there is a discrepancy
between the standards of public and private cord blood banks. In order to improve upon these
issues it is necessary to review the laws that are currently in place and then expand upon them so
that they better reflect the storage, use, and donation of the blood. If umbilical cord blood
becomes more than medical waste, as is projected to happen, then there is a need for an adequate
legal foundation that protects the interests of all parties involved, especially prospective parents.
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INTRODUCTION
It is estimated that there is a birth every eight seconds in the United States (United States
Census Bureau, 2014). In 2010 alone there were 3,999,386 births documented (Births and
Natality, 2014). Each birth that occurs without complications allows for the collection of
umbilical cord blood which can be stored and, if kept properly, used later to treat many diseases
(Verter, 2013).
Umbilical cord blood transplants began in 1988. The first documented treatment was
provided to a patient with Fanconi Anemia (Ballen, 2013). This marked the start of the transition
from considering umbilical cord blood waste to being potentially useful. This transition gave rise
to banking the cord blood.
Cord blood use and banking has gained the attention of prospective parents. This trend
has been sparked because of the ability to use the stem cells from cord blood to treat certain
diseases such as leukemia, lymphoma, and other immunodeficiency diseases (Mohapatra, 2013).
Umbilical cord blood contains stem cells which can develop as other cells in the body, which is
why it is able to be used and is an effective alternative to bone marrow transplants (Pinch, 2001).
The stem cells in the umbilical cord blood, when used in a transfusion, basically take over the
defective cells in a sick patient and begin to produce healthy cells (Pinch, 2001). It is important
to note that umbilical cord blood stem cells are not the same as embryonic stem cells. The cord
blood trend is a separate and less politically charged entity.
Embryonic stem cells are derived from an embryo for the sole purpose of retrieving cells
to provide a remedy to an illness and then typically discarding the embryo afterwards. Unlike
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embryonic stem cell collection, cord blood collection derives from the umbilical cord being
clamped and the blood then being extracted. The collection process is painless for both mother
and child. If done properly it can yield stem cells suitable for transplants (American Pregnancy
Association, 2014). Aiding in the rising trend of cord blood use is the fact that it is a painless
procedure and that the cells are readily available for use after collection and screening.
Although the use of stem cells from cord blood is possible, at this point transplants are
primarily performed in younger children. Cord blood transplants are primarily only done in
children due to the fact that a sample of cord blood does not always contain enough cells to be
considered an effective treatment for adults (Moninger, 2006). Considering children are the
primary audience it makes sense that parents are the target of marketing strategies employed by
public and private blood facilities.
Generally, the options available for the expectant parent are to either store the cord blood
in a private blood bank, donate the blood to a public cord bank for use in research or as a
potential treatment for an unrelated individual, or to discard the blood as medical waste. While
discarding the blood is still common practice, medical research is advancing in this area of study
which is why other, more useful, options are becoming available to parents.
Despite the primary audience being children, the medical community is still researching
ways to improve transplant availability to adults. A large reason for using stem cells retrieved
from the umbilical cord is that the cells are immature which reduces the necessity of having a
closely matching donor (Chen, 2013). In an effort to improve research, especially to help
increase availability to adults in need of a transplant, and to expand the amount of cord blood
available for transplants the federal government enacted the Stem Cell and Therapeutic Research
2

Act of 2005. The enactment of the Stem Cell and Therapeutic Research Act really focused in on
the potential of cord blood.
The law is aiming to match the needs and demands set forth by the increasing trend for
the use of cord blood. As this is a newer trend the storage, use, and donation of cord blood has
been met with many questions and concerns, especially from a legal perspective. Research in this
field is advancing and as a result the laws and regulations regarding umbilical cord blood are also
evolving in an attempt to ensure the protection of the market and consumers of cord blood.
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BACKGROUND
While the law currently covers the general use of cord blood it cannot feasibly address
every issue that is cropping up as a result of increased use. As storage, use, and donation of cord
blood expands, there is a prime opportunity to ensure sustainability of resources, accountability
of those involved with the storage of specimens, and the uniformity of collection and consent.
Laws regarding the storage, use, and donation of umbilical cord blood can be found on a
federal level and on a state level in most states (Folger, 2008). Congress initiated interest in the
use of cord blood when they enacted the Stem Cell and Therapeutic Act of 2005. From there the
Food and Drug Administration became the primary federal regulating agency for the use and
storage of cord blood.
The FDA has proposed regulations and guidelines for both public and private cord blood
storage for facilities within the United States and for those which are outside the United States
but distribute the cord blood within the United States. (Wall, 2010). The Food and Drug
Administration also outlined the steps necessary to be able to use cord blood in a transplant. This
framework provides the basis for the workings of public and private facilities.
On a state level, most states have enacted some type of law regarding cord blood. The
legislation does not generally provide in depth regulations, but are more concerned with ensuring
that parents receive information about their options for the cord blood (Parents Guide to Cord
Blood, 2013). The primary goal of the state laws is to inform parents, rather than protect them
should something go wrong when storing, donating, or using cord blood for a transplant.
Information is great, however, this falls short when the information is not consistent and is not
mandated.
4

Other issues being discussed include who legally owns the cord blood and what
constitutes informed consent. Both of these concerns are important for future liability issues that
can arise. Informed consent topics are relevant at the moment because for the most part "consent
policies and practices are not uniform" (Vawter, 2002). From a business perspective this can
detract from operations. From a parental perspective this can cause discrepancies between
expectations and actuality.
Cord blood storage, use and donation is becoming an important component of the
medical field. Like many new trends the law must also change to meet new demands. The
subsequent sections will outline some of the current federal and state laws as they stand now and
how they can be improved upon. Additionally, review of public and private banking practices,
and the concerns that arise from each will also provide a basis for where the law needs to address
growing concerns.
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FEDERAL LAW
Stem Cell and Therapeutic Research Act of 2005 and the Reauthorization Act of 2010
The Stem Cell and Therapeutic Research Act of 2005 was the initial congressional
interest in the use of cord blood as a means for research and for use in patients with life
threatening illnesses. The bill was enacted as Public Law 109-129 on December 20, 2005 after
being signed by President George W. Busch. The purpose of the bill was to “provide for the
collection and maintenance of human cord blood stem cells for the treatment of patients, and to
amend the Public Health Service Act to authorize the C.W. Bill Young Cell Transplantation
Program” (Govtrack, 2005).
The C.W. Bill Young Cell Transplantation Program was designed to expand on the Stem
Cell Act to increase the availability of stem cells derived through bone marrow and cord blood.
The focus for the program is on patients who require an unrelated donor for their transplantation.
Finding an unrelated donor can be an arduous task and this program attempts to streamline
information, to effectively communicate with patients, and to increase the odds of finding a
suitable donor (United States Department of Health, 2014).
The Stem Cell and Therapeutic Research Act was an important step by Congress,
allowing for increased funding for research and availability of cord blood for research and
transplant purposes. The goal was to collect and maintain 150,000 new units of cord blood. This
baseline number would allow for greater research and transplant options. In turn, it also allows
for a larger resource should there be increased demand.
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If samples that are received are not viable for transplantation the bill further stipulated
that they should then be available for “peer-reviewed research” (Govtrack, 2005). All of the
provisions in the bill were made to help provide more options for patients and to gather data that
can be used to show the effectiveness of cord blood. Additionally, furthered research can
improve the procedures necessary to increase collection and ultimately benefit adults as equally
as children.
The Stem Cell and Therapeutic Research Act of 2005 is important because it is the first
step in ensuring a patient has the option to receive a transplantation if necessary. Having a set
baseline will allow for availability of supply in relation to demand. This bill was effective in
achieving the outlined goals at the end of its prescribed term and for this reason was reauthorized
in 2010 by President Barack Obama.
The Stem Cell and Therapeutic Research and Reauthorization Act of 2010 maintains the
same premise of the 2005 Act. However, it does expand upon the initial goals of units of cord
blood to be collected. Additionally, it provides the possibility for qualified cord blood banks to
extend their initial contract lengths.
This is an important addition so that the banks can continue their work in research and
finding donor matches. In addition, funding for qualified banks is more clearly defined in this
bill and an extension of funding was granted through 2015 (Govtrack, 2010). Clarification is
necessary so that there is an understanding of who qualifies and how they are funded during the
prescribed term lengths.
Ultimately both the 2005 and 2010 bills were concerned with availability of resources.
Availability of cord blood allows for research and transfusions and an allocation of funding helps
7

solidify that research can continue. As cord blood use is still an emerging trend there needed to
be a two-fold “insurance” for resource availability.
Regulating Public and Private Cord Blood Facilities

The Food and Drug Administration is the main regulating agency for both public and
private cord blood facilities. They have procured a framework that enables the process of storage
and use to be possible. While basic blood and tissue practice must be followed, the involvement
of the FDA in the public and private facilities varies.
When cord blood is donated to a public facility the blood is classified as a drug. Cord
blood falls under the drug classification because of the therapeutic benefit derived through a cord
blood transfusion. For this reason when the blood is donated and further used in an unrelated
recipient the public cord blood bank will need to apply for a licensure.
Typically public cord blood banks will have to have the cord blood “licensed under a
biologics license application” or the cord blood will have to go through an “investigational new
drug application” prior to being used for treatment in unrelated patients (Food and Drug
Administration, 2012). This is an important regulatory establishment for the protection of the
patient. By filing for the licensure the blood must go through testing to help reduce risk of
translating disease. Approval for a biologics license and an investigational new drug application
can vary. For an investigational new drug application though there is usually a thirty day waiting
period prior to approval (U.S. Food and Drug Association, 2014). If the application is submitted
promptly upon receipt of the cord blood this time frame is suitable because the need for that
exact specimen may not be present yet.
8

Public donation facilities are held to a slightly higher standard than the private
counterparts. Private donation facilities must comply with standard blood and tissue practice.
This includes testing for infectious diseases. However, they do not have to go through the same
licensure process. The cord blood is still considered a drug but because the private facility stores
the blood for personal use the licensure is deemed unnecessary. Even if the specimen is used for
a family member, the familial relation supersedes the need for approval prior to use. This is not
to say though that private facilities are not regulated.
In addition to standard practice, private banks must also follow other regulatory
provisions. This includes establishment registration, donor testing, and compliance with current
good tissue practice regulations (Food and Drug Administration, 2012). The framework set forth
by the Food and Drug Administration is a basic skeletal model that allows for the practice of
using cord blood to be established.
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STATE LAW
For the most part, the purpose of state legislative acts is to inform expectant parents about
their options for cord blood. In the majority of states the legislative acts “mandates/encourages
physicians to educate expectant parents about all forms of cord blood banking” (Parent’s Guide
to Cord Blood, 2014). There are some states however that have notable differences in their
provisions.
Notable Differences in State Legislative Acts
There are currently twelve states that have varied the approach to the cord blood trend. It
is important to note these differences because they either go beyond what most states have
enacted, or they are entirely silent on the issue. Where this plays a key role is in the overall lack
of uniformity which can cause disruptions in information output and what standard practice is
considered. Highlighted here are a few with the most distinguished differences in their
legislative acts.
The first few states mentioned herein address the public awareness aspect of promoting
the cord blood trend. Virginia and Florida address the same concerns as the majority of states in
that they encourage physicians to talk with parents. They however address the concern of what
information to provide because they “explicitly endorse the use of educational materials from
Parent’s Guide to Cord Blood Foundation” (Parent’s Guide to Cord Blood, 2014).
Florida has implemented within its legislation that, “The Department of Health shall
make publicly available, by posting on its Internet website, resources and an Internet website link
to materials relating to umbilical cord blood which have been developed by the Parent's Guide to
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Cord Blood Foundation, Inc.[…]” Fla. Stat. § 381.06016 (LexisNexis 2014). Virginia has nearly
identical statutory language which is that, “[…] the Commissioner shall make publicly available,
by posting on the public website of the Department of Health, resources relating to umbilical
cord blood that have been developed by the Parent's Guide to Cord Blood Foundation[…]” Va.
Code Ann. §32.1-69.4 (LexisNexis 2014). Having states specifically endorse certain outlets for
information is a step towards standardization. Having one or two specific sources for information
adds to the overall ease of research that parents must conduct and ensures that everyone is
receiving either the same or relatively the same information.
Maryland’s legislative act regarding distribution of information is limited. They merely
prescribe that “The Department, in consultation with obstetricians, the Maryland Hospital
Association, and interested groups, shall develop educational materials concerning the values,
uses, and donation of umbilical cord blood […]” and that “[e]ach obstetrician and hospital that
provides obstetrical services shall distribute the educational materials […] to pregnant patients”
Md. Code, Com. Law §19-308.7(f)(1-2). While they do not necessarily have one source of
information they are notably different because they require that the educational materials be
distributed to all pregnant patients.
Wisconsin and New Mexico are important to mention as well. In their legislative act they
state that physicians are encouraged to inform parents about public donation options. This is an
important contrast because States typically encourage a balanced release of information between
public and private options. Wisconsin’s statute states that “the principal prenatal health care
provider of a woman who is known to be pregnant shall, before the woman's 35th week of
pregnancy, offer her information on options to donate, to an accepting and accredited cord blood
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bank, […], if the donation may be made without monetary expense for the collection or storage to
the woman” Wis. Stat. §146.343(2) (2014). The last part concerning monetary expense would
further prohibit discussion of most private storage options. New Mexico has similar language
though they do not expand on the ‘donation only’ mentality by including a monetary expense
portion to the statute. Their statute states that “all health care providers providing health care
services to a pregnant woman during the last trimester of her pregnancy, which health care
services are directly related to her pregnancy, shall advise her of options to donate umbilical cord
blood following the delivery of a newborn child. […]” N.M. Stat. Ann. § 24-27-4 (LexisNexis
2014). Considering umbilical cord blood use is a new practice it is reasonable for a state to focus
on public donation options as public donation can help expand research opportunities which can
further develop cord blood uses.
Arkansas includes in their legislative acts a provision that allows individuals to contribute
tax refund dollars so that an establishment of a public and/or private cord blood bank can be
created. It is part of their Newborn Umbilical Cord Blood Initiative and Ark. Code. Ann. § 2651-2508 authorizes a “tax check-off program” to be created that allows for a “means by which an
individual tax payer may designate a portion or all of his or her income tax refund to be withheld
and contributed [to the initiative fund].” Very few states offer this making it a comparatively
progressive idea.
Recognition of a need is important but means nothing if there is not a way to support it.
Arkansas has taken initiative to provide funding sources outside of the typical allocation of state
funds. This offers a way for the budget to be increased without reducing funds from other parts
of the state budget. Of all the aforementioned states Arkansas is one of the few that strikes a
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balance between recognition of potential and implementation of means to explore the potential.
Most states right now are not at that point.
Mississippi: Taking the Use of Cord Blood One Step Further
On April, 23, 2013 the state of Mississippi announced the approval of House Bill 151
which requires physicians and midwives to collect the cord blood of a child born to a mother
under the age of 16 who fails to name the father of the child. The state is stating that in this type
of circumstance that there is a suspicion of statutory rape. The cord blood is to be collected so
that a DNA test can be run to determine the father and possibly pursue a statutory rape case
against the father (Hess, 2013).
In the statute it is stated that “[w]hen a minor who is under sixteen (16) years of age
gives birth to an infant, umbilical cord blood shall be collected, if possible, in accordance with
rules and regulations adopted pursuant to this section if it would be reasonable to suspect that the
minor's pregnancy resulted from a sex crime against a minor” Miss. Code Ann. § 97-551(5)(a)(ii)(LexisNexis 2014). Additionally they provide that “[a] health care practitioner or
health care facility shall be immune from any penalty, civil or criminal, for good-faith
compliance with any rules and regulations adopted pursuant to this section” Miss. Code Ann.§
97-5-51(7)(LexisNexis 2014). While the statute prescribes penalties for those convicted based on
the evidence of the cord blood it is silent in regards to whether there is a penalty if the cord blood
is not collected.
The theory behind this statute is that through its enactment the number of teen
pregnancies will be reduced in the state. While the potential to reduce the number of teen
pregnancies is plausible, there are associated legal concerns through the enforcement of the
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statute. For starters, the mother has the right to not name the father. Additionally, taking
possession of the cord blood would invade upon the privacy of the mother and father. If the state
steps in as it plans to there is an infringement on rights that the mother and father both should
have.
In addition to privacy rights, the mother, despite being a minor should still have the right
to retain possession of the cord blood for private banking or for donation to a public bank. Based
on the statute, suspicion of statutory rape is enough to require collection of the cord blood for use
in a paternity test. If the pregnancy raises suspicion of statutory rape, is the mother still required
to forgo her right to retain possession of the cord blood so that the state can identify the father?
On a more practical level, there is a question of whether testing on the cord blood will
destroy the possibility of the child or public being able to use the cells. Cord blood stem cell
collection is still a relatively new practice. As of now the number of stem cells found in the cord
blood is low and as such the yield of stem cells can traditionally only provide benefit to children.
If the state steps in and requires testing of the cord blood can they guarantee that the full
potential yield of cord blood stem cells is still achievable? If it is not, this may reduce the
opportunity for the child to receive an effective therapeutic reaction to the transfusion. Assuming
the child could have used his/her own cord blood said child may now need to rely on a public
donation facility rather than his/her formerly viable cord blood specimen. In this case the child is
at a greater disadvantage.
In addition to these issues, it is still widely debated whether the cord blood belongs to the
child or to the mother, but there is yet a mention of the cord blood belonging to the state. The
only time the state can really claim things removed from the body is if it is to be regarded as
14

medical waste. For this reason is it even ethical that the state mandates the collection of the cord
blood? The state certainly does not own the cord blood or truly have a vested claim to it, so the
state dictating what must be done with the cord blood in this situation seems contrary to the
rights of the mother. This statute in particular is troubling, especially if other states begin to
follow Mississippi’s lead prior to an establishment of the true extent that the provisions can be
applied.
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PUBLIC VS. PRIVATE CORD BLOOD BANKS
Unlike embryonic stem cell testing, umbilical cord blood is fairly non-controversial. The
largest debate surrounding cord blood is the issue of storing it privately or donating it publicly.
Each situation has its merits but very few are willing to concede that private storage is a better
option.
Public cord blood donation facilities are a benefit to society as a whole. This is because
cord blood donated publicly have the potential to be used for any HLA matched recipient.
Private donation facilities on the other hand serve an individualized need. The following sections
will outline the standard operation of public and private cord blood banks and whether private or
public cord blood banks are a better option.
Public Cord Blood Banks
Public cord blood banks allow for the collection of umbilical cord blood that can later be
used for unrelated patients in need of a transplant. The benefit of public cord blood banks is that
there are more samples to choose from in the collective pool. This means that patients with life
threatening diseases have access to more viable options for their transplants.
The purpose of public donation facilities is to enable research and further to provide a
diverse selection of specimens for transfusions. Diversity of blood specimen in a public facility
is important so that every individual theoretically has the possibility of finding a matched donor.
Public cord blood banks look to the collective good for society.
A parent has the option to donate the cord blood of their child to public banks, but this
option is not always discussed with parents. Many prominent organizations, such as the
16

American College of Obstetricians and Gynecologist, (furthermore ACOG), support donation of
the umbilical cord blood.
In a statement released in February 2008, the ACOG advised that “physicians should give
balanced information to their pregnant patients who are considering cord blood banking,
presenting both the advantages and disadvantages of public vs. private cord blood banks”
(ACOG, 2008). They also recommended “that physicians disclose that there is no reliable
estimate of a child's likelihood of actually using his or her own saved cord blood later” (ACOG,
2008). While the ACOG states that they are not for or against cord blood banking, it is
reasonable to assess that based on the recommendations made they are more inclined to public
storage options.
Public donation is important in order to further study the benefits of cord blood.
However, donation is not always a feasible option. Firstly, there is a lacking number of public
donation collection sites. Not every hospital has the resources to collect the cord blood on behalf
of a public facility. According to Be the Match, only twenty-four states have hospitals that
partake in the collection of the umbilical cord blood for public donation. Of those twenty-four
states, half have five or less participating hospitals that will collect the cord blood for public
donation. Due to the lacking availability of participating hospitals, parents will likely have to
travel farther distances to a hospital if they wish to donate the cord blood. There are a select few
public donation facilities that will accept mail-in donations, though typically they only accept
donations from residents of the state in which the facility is located.
There is a quick turn-around time for donation. The cord blood needs to be properly
stored to remain viable. As such, the donation facility in which arrangements have been made to
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donate to typically need to be notified within a few hours after the cord blood has been collected
so that a courier can be sent out within the next day. This quick turnaround is necessary so that
the blood remains properly stored and is able to be processed.
Parents will have to do a lot of research and preparation if they choose to proceed with
donation. An expectant parent may not have the time, either they are too far into their pregnancy
or for other reasons, or energy to research and plan. This is an added stress to the parents and
can discourage prospective donors. If they do proceed with donation though there is generally no
costs associated with the donation. It is possible that the collecting physician may charge for the
collection of the cord blood, but the donation facilities generally do not charge for a donation.
Second, from an operations standpoint the costs associated with a public donation site are
high. There is no cost for the parent to donate the blood which means that the public cord blood
facility bears all of the costs. They “pay for the collection, testing, and storing of umbilical cord
blood” and do not recoup their initial expenses until a unit of cord blood is used by a future
recipient (Health Resources and Services Administration, 2014).
A unit of cord blood can run upwards of $30,000, but this expense can be covered by a
patient’s insurance. This means that even when a sample is used there is not a guarantee of any
immediate payment. A further look into the numbers shows a logical reasoning for limited public
donation facilities.
It is estimated that a public bank will incur costs between $1,500 and $2,500 per unit of
cord blood collected. These numbers are prior to licensure requirement costs. Typically, the
reimbursement by the federal government is only about $1,282 of the initial incurred costs.
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These numbers alone show why operating a public bank can be costly and therefore there is slow
progress in implementing more public cord blood banks (Verter, 2013).
When costs are high, and incurred without guarantee of payment or reimbursement there
is a difficulty presented for the implementation of these storage facilities. The business model
itself is counterproductive to the overall goals. While public cord blood banks are highly
regarded, and are inherently the goal of the Stem Cell and Therapeutic Research Act, they are not
a prominent option at the moment due to the high funding costs required to operate and maintain
the facilities in accordance with current FDA regulations.
Private Cord Blood Banks
Storing cord blood in a private bank is often times the option that expectant parents are
bombarded by. Private cord blood banks are costly to store the cord blood in. To segue around
the high costs, operators of private blood banks capitalize on the emotional vulnerability of
expectant parents.
Many private cord blood banks have persuasive advertising which can easily lead
expectant parents to believe that they are providing “insurance” for their child by storing the cord
blood. When presented with the idea that their child can be cured from leukemia, lymphoma, and
other diseases there is little hesitation for making the decision for storing the cord blood. When
looking at such advertisements, parents are lulled into believing that money is not an object when
it is possible to save their child from potential life threatening diseases.
What parents often do not realize though is that the claims made by private cord blood
banks are over exaggerated. In fact it is estimated that the likelihood of a child using his/her own
cord blood is less than a 0.04 percent chance (Mohapatra, 2013). In addition to this it is also
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possible that should the child need the cord blood he/she will not be able to use it because the
genetic defect causing the illness is present in the cord blood sample as well (Mohapatra, 2013).
As mentioned in an article released by Parents.com, a woman stored her child’s cord
blood in a private bank. When she learned that her son was diagnosed with a potentially fatal
disease, and one that using the cord blood would be effective against, she requested that the
stored blood be used for treatment. What doctors ultimately told her was that the umbilical cord
blood could not be used because what was causing the illness in her child was found in the
genetic material of the blood, meaning that even if a transplant occurred it would not help to
eradicate the illness (Moninger, 2013). Up until that point she was unaware that this could
happen and did not find out until after having stored the cord blood. This is not an uncommon
occurrence.
Misleading advertising is not the only problem that parents face when storing the cord
blood in a private bank. Issues of failed health inspections and lack of maintenance of the cord
blood units, mislabeling of blood units and other discrepancies contribute to a child not being
able to use the cord blood when it is needed.
In these situations one may ask how it is possible for the privatized cord blood banks to
continue in this manner. The simple answer is that they should not be able to. The Food and
Drug Administration does have regulations that the private banks are to follow. They require that
private banks follow current FDA regulations “including establishment registration and listing,
donor screening and testing for infectious diseases (except when used for the original donor),
reporting and labeling requirements, and compliance with current good tissue practice
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regulations” (FDA, 2015). Where the problem lies though is that some of the privatized cord
blood banks simply do not follow the regulations.
The Food and Drug Administration will conduct health inspections and ensure that
current practice standards are met. If they are not being met they can force the shutting down of
the private banks, but by the time it reaches that point the blood bank in question is likely already
severely incompliant. This can mean anything from the cord blood bank failing to maintain
proper temperatures in the facilities, failing to maintain a clean facility, or abandoning the
facility altogether. What this causes is the inability to use the cord blood that is stored in such
facilities because the samples will have been compromised. It is for the compilation of
aforementioned reasons, (low odds of personal use and incompliant facilities), that many high
ranking health organizations, such as the American College of Obstetricians and Gynecologists
and the American Association of Pediatrics are hesitant to recommend the utilization of private
storage facilities.
While there are issues that face private banking, Congress realizes that private storage is
as much a part of the cord blood trend as public donation is. As such, H.R. 3673, the Family
Cord Blood Banking Act, was introduced on December, 5 2013. The purpose of this bill is “[t]o
amend the Internal Revenue Code of 1986 to treat amounts paid for umbilical cord blood
banking services as medical care expenses” (Congress.gov, 2013).
Providing the incentive of a tax break would be a benefit to the individual who is storing
the cord blood. There are high costs associated with private storage so being able to write it off
as a medical expense could help mitigate this. However, because cord blood use is still an
emerging practice, the main focus right now should be on public donation. The purpose of the
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Stem Cell Therapeutic Act of 2005 (2010) was to increase the donated supply of cord blood and
other stem cell specimens. As of this writing there is not a tax incentive for donation of cord
blood, nor is there a proposed tax incentive for donation of the cord blood. So, it is very possible
that people will further consider storing blood in a private bank over donating to a public bank.
This could have a negative effect to the initial goal of the Stem Cell and Therapeutic Act of 2005
(2010). This tax incentive proposal would be better suited for a time when the benefits of private
storage begin to either equal or outweigh those of public donation. Until that point though efforts
should remain concentrated on public donation.
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OTHER LEGAL CONCERNS REGARDING CORD BLOOD
The main controversy surrounding umbilical cord blood is the debate over private v.
public storage. This is not the only issue that has arisen as a result of cord blood use. Ownership
rights and informed consent are also prevalent. It is also important to shed light on the privacy
rights of the mother and child.
Ownership of Cord Blood
Ownership rights is a pressing issue for both public donation and private facilities. In the
public sector the mother must consent to donation of the umbilical cord blood. If the mother
donates the blood then there is an expectation that she does, at one point, have ownership of the
cord blood. It is common thought that at the point of relinquishment that the limited property
interest in the blood is relinquished.
This is an important note because if the donation facility uses the cells in a manner that
the mother was not anticipating a court will likely deem that the mother has no interest in the
blood and therefore the facility is within its rights to do with the sample as they please without
the full consent of the mother (Kirchenbaum, 1997). It is important for a mother to understand
that after donation she no longer has a claim to the umbilical cord blood. If her child requires the
blood at a later date the sample may not be available.
In the private sector ownership rights stem from whether the mother or child owns the
blood. The arguments made are that the umbilical cord and the blood within are entirely a part
of the baby as it is growing and developing deeming it the child’s property. However, adult stem
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cells can be found within the cord blood and that once the cord is cut it is the mother’s property
(Petrini, 2010).
In an effort to answer the question of ownership a typical private cord blood agreement
will dictate that the mother is engaging in the contract on behalf of the child, acting as an agent.
Once the child reaches the age of majority it is deemed that control of the sample is appropriated
to the child. For example, in a contract found through Cryo-Cell international, the language of
the agreement states that “Cryo-Cell does not have a contract with the child” but that “When
[the] [c]hild has reached the age of 18, [the] [c]hild has ownership claims […]” (Cryo-Cell,
2015). This would suggest that the mother is acting as an agent on behalf of the child and that
the child actually owns the specimen.
Where this becomes controversial is if a sibling needs to use the cord blood for a
transfusion. Depending on the language of the contract, the mother may not have full authority to
allow the cord blood to be used for a transplant in a sibling. It is generally not specified if the
mother has any right to the blood at all other than to ensure that it is stored. This would be the
point in which the court would be called to step in for the determination of whether the mother
has the ability to consent to the treatment.
While there is not current case law that focuses on the consent of cord blood transfusions
in siblings there is plenty regarding organ transplant. When it comes to an organ transplant and
the donor is either a minor or incompetent the parents may not have authority to consent to the
transplant. When left to the discretion of the court they will look for signs of whether the
transplant will benefit the donor and donee. They take into consideration familial ties and
bonding, and if they do not see that there are strong ties they will likely state that the operation
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should not take place (Kirchenbaum, 1997). For example, Strunk v. Strunk 445 S.W.2d 145
(1969) was a case that came out of the Court of Appeals of Kentucky. A mother and father had
two sons. Tommy Strunk was considered to be legally competent and was suffering from a fatal
kidney disease. The other son, Jerry Strunk was 27 and considered to be incompetent, having the
mental age of a six year old. However, he was a donor match for the ill brother and the parents
petitioned the court to allow them to act on the son’s behalf so that the kidney transplant could
occur. The court looked to the brother’s relationship and determined that if Tommy were to die it
would be more traumatic on Jerry than if he were to undergo surgery for the kidney transplant. It
was the emotional attachment between the brothers that ultimately persuaded the court to grant
the parent’s the right to act on behalf of Jerry Strunk. Other cases have since followed citing to
Strunk v. Strunk when the determination for parental consent for a procedure on behalf of a
minor or incompetent child is needed.
If cord blood transplants between family members follows this same schematic it would
be reasonable to assume that the parents do not have authority over the cord blood sample that
they are merely ensuring its protection until the child it was retrieved from reaches the age of
majority. It may be possible them to make decisions if they are regarding the child that the
sample was taken from, but beyond that it may be a matter for the courts to resolve.
If the aforementioned holds regarding cord blood transfusions then it would also be
reasonable to assume that there are limited property rights associated with the cord blood. This
presents another problem. If there are limited property rights then no one actually owns the cord
blood and the questions regarding medical decisions remain unanswered.
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If for arguments sake the mother is the owner, then many of these questions are
foregone. The mother can consent to the use of the cord blood for medical treatment in a sibling
without issue. Considering that the purpose of storing the blood is for potential later use, this
only adds to the overall benefit of storing the blood. Additionally, if it is deemed that the mother
owns the blood then there is little recourse that can occur if the mother chooses to donate the
blood.
To the contrary, if it is the child’s property then there can be concern that by the mother
donating the blood for public use there is a “contradiction to the principle of the autonomy of the
child and the donation is being done without the child’s knowledge” (Petrini, 2010). What this
means is that, while the mother has guardianship of the child, the child in the future may not
approve of what the mother has done with the cord blood. This line of thought can ultimately
unravel the entire prospect of donating to a public cord blood bank.
These questions call for clear legislation regarding the potential issue of ownership. What
can be defined is whether ownership rights should be established and who then owns the blood.
If these concerns are mitigated through legislation then cord blood use is one step closer to
operating at a more efficient level.
What Constitutes Informed Consent
By definition, informed consent is the “consent of a patient or other recipient of services
based on the principles of autonomy and privacy” (Medical Dictionary, 2015). For the purposes
of cord blood collection it is important to keep this in mind. While important, it can be hard to
reconcile textbook definitions with practice.
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A consent form must be signed by the mother in order to either donate or store the cord
blood for future use. In terms of donation, the form traditionally states that the donor understands
how the collection process works and that there are issues that can arise through the collection
and use of cord blood. Typically an expectant parent should be informed and give consent prior
to “the onset of labor when the donating mother is able to fully understand what is involved and
is not distracted or under anesthesia” (AABB, 2014).
It is determined that informed consent should take place at some point during the third
trimester prior to labor. This however is not a steadfast rule. When donating publicly, the timing
of informed consent is important. Once the donation is made any claim to the blood is
relinquished by the mother. The mother needs to be fully aware of what she is doing when
donating the sample and understand that once the donation is made the cord blood may not be
available to her any longer. This is important so that if there is ever a dispute regarding whether
the mother was made fully aware the public facility is covered and allowed to continue to
operate.
In an ideal situation consent will be rendered prior to labor. However, this is not always
possible. If a mother has stated that she would like to donate the cord blood but goes into labor
prior to giving consent, the donating mother can sign a “’mini’ consent form allowing collection
of the cord blood during labor, and administrators will “meet with her after she recovers from the
delivery to educate her and obtain full informed consent” (Kurtzber, 2005).
Unlike public donation, private cord blood banks allow the donating mother to sign an
agreement and consent form at any time. Typically they will be signed prior to labor but this
does not have to occur in order for a storage facility to accept the agreement and consent form as
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valid. So long as everything is in order prior to storage the mother has some time to consider her
options.
There are additional challenges that informed consent brings outside of timing. The
donating mother needs to be aware that by donating the cord blood she herself, and the cord
blood, will need to be tested so that there is a documented medical history. This is an extensive
testing for the presence or pre-disposition of disease. Any genetic information garnered from the
testing is attached to the sample and kept for the record. Testing of the cord blood is also done by
a private facilities. The information is gathered so that it can be determined whether the child
will be able to use the specimen. Due to the extensive medical and genetic data collected through
the testing of the cord blood it is imperative that a consent form addresses what the data is going
to be used for.
The aforementioned tends to be the largest point to a consent form but certainly not the
only. It is also used to ensure that the donating mother understands that there are not currently
any studies that test the “long-term viability of cryopreserved cord blood” given that the use of
cord blood has not had a long history (Martin, 2011). The mother also needs to know that
regardless of whether she would like to donate or store the cord blood it is possible that
collection may not occur if complications during labor occur.
Having informed consent not only protects the mother, but it also protects the hospitals
along with the private and public cord blood banks. Having a lack of standardization in how and
when informed consent is collected gives rise to the possibility of a variety of law suits. A
donating mother may feel cheated, or that she did not have enough, or adequate, information to
fully realize what she was doing by choosing to donate or store the cord blood.
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This could have significant backlash on the hospitals and cord blood banks. Bad publicity
can reduce the amount of willing donors and consequently the number of available, and useable,
cord blood units. In addition to the potentially fewer donations, a public bank may not have the
means to financially endure backlash from a donor. This is especially so if there is a substantial
claim. A private storage facility is less likely to have the same backlash because the terms of
agreement outlined in the contract tend to reduce overall liability for the private storage facility.
Who Can Give Informed Consent?
Timing of consent, and the information presented in the consent form are important.
Another consideration that needs to be made though is whether a mother’s consent alone is
sufficient. The argument is that the father may need to consent to either donation or storage of
the cord blood depending on the method of extraction.
Cord blood can be collected either in utero or after the placenta is outside the uterus. It is
believed that “if the cord blood is removed while the placenta is still in the uterus, generally the
mother’s consent is sufficient because it is an extension of her body” however, “if the cord blood
is removed after the placenta has been taken from the mother’s uterus, […], an argument could
be made that the father’s wishes are also relevant […]” (Meyer, 2005).
A mother and father both have rights in deciding how best to ensure the well-being of
their child. If a father’s wishes were to play a role there is now another factor that a consent form
must make consideration for. As previously mentioned, the purpose of the consent form is to
protect both the patient and the banking facility. If it is deemed that they have not obtained
adequate consent then there are consequences that will result.
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Timing once again plays a role in informed consent conditions. Additionally,
determination of whether both parents must consent to the collection of cord blood can tie into
ownership issues. If the mother owns the blood then it would be reasonable to believe that her
consent alone is adequate. If however the child owns the blood, or even if it is jointly owned
between parents, then it would be reasonable to believe that the mother and father must both
consent to collection. Ownership and informed consent issues have a cyclic nature in which
answers to one issue can help shed light on the other.
In the Interest of Privacy
Questions regarding privacy are often raised when donating the umbilical cord blood.
Extensive medical tests are performed to determine whether the mother has a disease or is predisposed for disease. Additionally, a mother must fill out a medical history questionnaire in order
to donate. All of this information is linked with the donated specimen. The information collected
is considered to be sensitive and therefore it is understandable that the mother would have
concerns over maintaining her, and her child’s, privacy.
In order to maintain privacy sensitive medical data is encrypted and a number is assigned
to the cord blood specimen. Names are never attached. A recipient for the donation would not
know the name of the mother or child, only that the blood was an HLA match. Likewise, if a
specimen was utilized for research, the researchers would not have access to identifying
information but only the specimen and information necessary to carry out the research.
As medical practices advance however, it may be necessary to construct new methods of
ensuring privacy. There are large amounts of genetic information associated with the cord blood.
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If medical practice allows the potential of constructing a visual of the donor based on the
information then current privacy practices will fall short.
Privacy standards have been updated and enforced by the Health Insurance Portability
and Accountability Act, (furthermore HIPAA). The purpose of HIPAA is to make sure that
patients are granted their privacy and that health information is not released unnecessarily. This
is important for cord blood donation and storage because of the genetic and health information
associated with the specimen. It is important to note though that HIPAA may not apply to every
organization. While it is typically enforced for both storage and donation practices it is not
enough to assume that HIPAA will apply in every situation. For this reason it is important for the
mother, or parents, to review whether the facility falls under HIPAA and how they will be
protected if it does.
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RECOMMENDATIONS
Umbilical cord blood can be an effective alternative to bone marrow. The efficacy of
cord blood is still being tested and as such it is not yet used as part of a common medical
practice. That is not to say that it never will be though. Now is the time to ensure that legal
concerns are addressed for when cord blood is accepted as common practice.

Moving From Availability to Sustainability
The Stem Cell and Therapeutic Research Act of 2005 and the Reauthorization Act of
2010 have provided the basis for the availability of cord blood samples. Now that the availability
is present the next step is to create sustainability. Cord blood use is becoming even more
popularized and research needs to continue. As storage, use, and donation increases, availability
of a cord blood supply must be ensured. Availability will also aid researchers as they can
continue their work without running the risk of not having specimens to test and develop
procedures from. Sustainability will be an issue that needs to be addressed both at a state and
federal level.
There are increased numbers of people being born each year. This can provide both the
answer to and a challenge for sustainability. More births mean more opportunities for collection
of cord blood. However, it also means a larger population who may need cord blood
transfusions. Public donations are the best means for servicing a larger population who may need
a transplant. To follow through on increasing donations, hospitals, instead of operating under an
opt-in program for collection should operate as an opt-out program. This means that unless
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parents otherwise object the cord blood will be collected for public donation. This will not only
help increase sustainability but will also aid in ensuring cord blood becomes more than medical
waste.
The above recommendation would require that hospitals be equipped with the means to
collect the cord blood and overall would be feasible to implement however there are alternatives.
Congress can propose a plan to incentivize public donations of cord blood. Incentives are an
effective motivator and can really increase unit availability. This incentive based program does
not necessarily need to be payment for donation but could be something as simple as an
increased tax credit in the Internal Revenue Code.
Another creative approach, one that moves entirely away from monetary benefits, is to
create a standing agreement that if a public donation of cord blood is made, and either the
eligible child or eligible nuclear relative have future need for a cord blood transfusion that said
individual be classified as a priority for receiving the transfusion. If that were to be a valid option
additional parameters would need to be set up. For example, a time limit for the agreement to
remain valid, at what point an individual must be named, and at what stage in the individual’s
condition that the provision for being classified as a priority can take effect. Additionally, it may
be important to note that eligibility is limited to current medical practices and whether or not
there is therapeutic benefit for the individual to receive a transfusion based on cord blood cells.
Further definition of eligibility should also include the threshold at which the individual must
meet or exceed in terms of perceived therapeutic benefit. In theory, providing an incentive, can
ensure that more units are going to better uses than medical waste.
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Room for Improvement: Federal and State Legislative Actions
Federal:
Cord blood can effectively be use for medical treatment. With this in mind federal
regulations need to be modified so that everyone has access to this potential, that consumers are
adequately protected, and that there is a clear definition of who owns the cord blood.
Improving access to cord blood can be aided by increasing sustainability of cord blood.
Healthcare is a top priority, and with the vast number of births that occur each year in the United
States there is a large potential yield of cord blood specimens. In order to tap into this potential
though public donation facilities need to be better funded, and more hospitals need to be
equipped with the potential to collect the cord blood.
Increased funding alone will not solve the problem entirely. For as long as private
banking options exist there is a portion of cord blood specimens that will be deviated for an
individual purpose rather than a collective one. While it is not suggested that private banking
should be stopped, because there are instances where private storage is useful, federal regulation
should address advertising concerns and those of reliability. Private cord blood banks need to be
held to a higher standard of accountability. This can be addressed by more frequent health
inspections, and more rigorous guidelines for how to properly keep a specimen, (i.e. not allowing
for the movement of a specimen continuously back and forth between facilities).
Advertising regulations for private storage should also be taken into consideration
because of the emotionally vulnerable state of expectant parents. Regulations should address the
issue of marketing tactics that prey on the emotional state versus advertising the reality of the
situation. Claiming that the cord blood is a “life insurance” of sorts but belittling the fact that the
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specimen likely will not be used is a tactic that raises serious ethical concerns. A balance needs
to be struck so that parents are given adequate and accurate information prior to choosing to bank
privately. Until marketing tactics are addressed through regulation though private banks will
continue to capitalize on the emotional vulnerability of parents.
Congress can address issues related to informed consent and ownership. For starters, cord
blood needs to be identified as a unique medical treatment. This is so that ownership rights can
readily be applied to the specimen. If legislation clearly notes who owns the specimen, i.e. the
mother, the child, or the blood bank, then the scope of the rights of the owner can be more easily
understood and represented.
In terms of informed consent, adoption of a unanimous standard will help protect
consumers. A federal standard will ensure that informed consent is properly retrieved and within
the appropriate time-frame. It should address which trimester consent must be garnered by. It
should also address what needs to be included in the agreement. For example, it should be
disclosed that the donated sample may be used for means outside of the conceived scope of the
informed consent contract.
State:
Many states have established a provision encouraging physicians to educate parents on
their options for the cord blood. However, there needs to be a more proactive approach. This
approach needs to be a two-fold process.
Firstly, we need to move past encouraging physicians to educate parents and instead
mandate that physicians inform parents of their options. Mandating that physicians educate their
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patients about their options will mean that more people become aware of the benefits from the
use of the cord blood which in turn can increase donation. Due to varying religions, states that
mandate physicians to inform their patients about their options take into consideration religious
conflicts. They do so by allowing physicians to forgo informing their patients if there is a
religious conflict.
If a provision were to require a physician to educate expectant parents it would also be in
the interest of the physicians to include a provision that protects them from liability if a parent is
unsatisfied with their choices and tries to blame the physician. This is an emotional time for
parents and a physician should not be at risk for simply increasing awareness of an emerging
topic.
A discussion covering both public and private cord blood banks should occur with an
objective presentation of the facts for both. If state legislators were to enact such a provision
there also needs to be a standard set of information that the physician is required to pass along.
This way there is not a wide variance of information based on a physician’s personal beliefs.
Additionally, this information should be presented to the parents prior to the third trimester.
At this time there is not a large amount of collection sites that will allow for the
collection of cord blood for public donations. For this reason a parent needs time to properly plan
if they decide to publicly donate the cord blood. Without proper planning and research it is
possible that donation of the cord blood will not be feasible.
Having said that, the next part that state legislation should address is the lack of hospitals
willing to collect cord blood for public donation facilities. This is a state issue versus federal
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because each state is going to have to address their financial standing and how implementation of
more collections sites can be a possibility. Whether it be physician education, funding, or both
each state should look into how to increase the number of locations. What this will allow is
increased availability for parents, potentially shorter commutes which reduces the risk of not
making it to a collection facility, and will ultimately help improve the overall sustainability of
the supply within the public cord blood facilities.
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CONCLUSION
Cord blood is a viable option to replace the use of bone marrow in transfusions. It has
been shown that cord blood is just as effective as bone marrow in treating certain life threatening
diseases. At this point though the main audience for a cord blood transfusion is children, with the
hope of finding ways to increase adult responsiveness.
The collection of cord blood is painless for both mother and child. There are many
benefits adding to the favor of the use of cord blood over bone marrow. The increasing trend for
collection, storage, and use of cord blood has not been met without a rise in legal issues and
concerns though.
It is possible to address these concerns now. In doing so it is possible to pave the way for
cord blood use to become more widespread. Overall, the umbilical cord blood is important. It is
necessary to shy away from the traditional notion that it is medical waste. Cord blood stem cells
do not pose the same social and political controversy that embryonic stem cells do which adds to
the favor of using cord blood. As of this writing research is also being completed on how the
umbilical cord itself can be used for therapeutic treatment of disease.
Right now, there are endless possibilities for cord blood, but research needs to be able to
continue in this area. If stability of supply is ensured, practice procedures are standardized, and
legal concerns answered now, by the time cord blood use is common practice there will be a
smoother transitional period.
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